The EU's formal antitrust probe into Meta could set a global precedent for AI governance, creating winners and losers across the tech landscape.
Companies championing open AI ecosystems could see increased user adoption and developer interest as regulatory pressure mounts on closed platforms.
This investigation targets the heart of big tech's competitive moat, potentially reshuffling market dynamics in favour of more flexible alternatives.
The EU's formal antitrust investigation into Meta's WhatsApp AI policies represents a pivotal moment for tech regulation. This probe challenges the 'walled garden' approach where dominant platforms favour their own AI services over competitors. Our analysts believe this regulatory shift could create significant opportunities for companies operating open ecosystems and alternative platforms.
This group includes major tech platforms, communication services, and AI specialists positioned across the regulatory divide. Some companies face scrutiny as dominant players, whilst others stand to benefit from more open competition. The regulatory outcome could establish a global precedent for AI governance and platform interoperability.
These companies were handpicked by professional analysts based on their strategic positioning around the EU's AI regulation push. The selection includes both companies under regulatory pressure and those positioned to gain market share in a more open, competitive environment where third-party AI services can compete freely.
The EU's antitrust investigation into Meta for blocking rival AI on WhatsApp signals a major regulatory challenge for big tech's platform dominance. This could create opportunities for other platforms that champion open AI integration, boosting their user engagement and market share.
The basket's total market cap is $6.65T and is heavily anchored by a few very large-cap stocks, indicating a pronounced large-cap bias that generally implies lower volatility.
META: $1.67T
GOOGL: $3.84T
CRM: $235.58B
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitiv Ltd.
If you invested across these assets:
In 12 months it might be worth:
+18.38%
On average, analysts expect assets in this group to grow 18.38% over the next year.
12 of 15 assets in this group are rated Buy by professional analysts.
